[1]王雅琴 张军**.心脏疾病患者宫腔镜手术围术期继续原有抗栓方案的安全性分析[J].中国微创外科杂志,2018,18(11):986-988.
　Wang Yaqin,Zhang Jun..Perioperative Safety Analysis of Hysteroscopic Surgery in Patients With Cardiac Diseases Receiving Antithrombotic Therapy[J].Chinese Journal of Minimally Invasive Surgery,2018,18(11):986-988.
点击复制

心脏疾病患者宫腔镜手术围术期继续原有抗栓方案的安全性分析()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
18
期数:
2018年11期
页码:
986-988
栏目:
临床研究
出版日期:
2018-11-20

文章信息/Info

Title:
Perioperative Safety Analysis of Hysteroscopic Surgery in Patients With Cardiac Diseases Receiving Antithrombotic Therapy
作者:
王雅琴 张军**
（首都医科大学附属北京安贞医院妇产科，北京100029）
Author(s):
Wang Yaqin;  Zhang Jun.
Department of Obstetrics and Gynecology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, China
关键词:
抗栓治疗; 心脏疾病; 宫腔镜手术; 围术期
Keywords:
Antithrombotic therapy; Heart disease; Hysteroscopy; Perioperative period
文献标志码:
A
摘要:
目的探讨心脏疾病患者宫腔镜手术围术期继续原有抗栓方案的安全性。 方法选择2015年1月~2017年6月我院合并心脏疾病需抗栓治疗患者行宫腔镜手术59例作为研究组，配对同期无抗栓治疗的同类型宫腔镜手术59例作为对照组。研究组围术期继续原有抗栓方案。2组术前血红蛋白、血小板计数差异无统计学意义（P>0.05）。研究组凝血酶原时间（PT）、国际标准化比值（INR）大于对照组（P<0.05）。比较2组术中出血及术后不良事件。 结果2组术中出血、手术时间差异无统计学意义（P>0.05）。研究组2例因术后出血多行二次手术。结论对抗栓治疗心脏疾病患者，术前充分评估出血及血栓风险，维持稳定凝血功能，围手术期继续原有抗栓治疗方案进行宫腔镜手术是安全的。
Abstract:
ObjectiveTo investigate the safety of hysteroscopic surgery for antithrombotic therapy in patients with heart diseases.MethodsFrom January 2015 to June 2017, 59 patients who needed hysteroscopy combined with antithrombotic therapy for heart diseases were selected as the research group, and another group of 59 patients who needed the same hysteroscopy without antithrombotic therapy were paired as the control group. The research group continued the antisuppository scheme during the perioperative period. There were no significant differences in hemoglobin value and platelet count between the two groups (P>0.05). The prothrombin time (PT) and international normalized ratio (INR) in the research group were greater than those in the control group (P<0.05). The intraoperative hemorrhage and postoperative adverse events during the perioperative period of the two groups were compared.ResultsThere were no significant differences in intraoperative bleeding and operative time between the two groups (P>0.05). Two patients in the research group were reoperated for postoperative bleeding. ConclusionsFor patients receiving antithrombotic therapy for heart diseases, assessment of the risks of bleeding and blood clotting to maintain stable blood coagulation function is necessary. It is safe to perform hysteroscopy surgery with previous antithrombotic treatment.

参考文献/References:

[1]de Jong JS,Vink R,Henny ChP,et al.Perioproperative suspension of anticoagulants:practical recommendations. Ned Tijdschr Geneeskd,2009，153（33）:A83.
[2]Douketis JD,Berger PB,Dunn AS,et al.The perioperative management of antithrombotic therapy American College of Chest Physicians EvidenceBased Clinical Practice Guidelines (8th edition).Chest,2008,133(6 Suppl):299S-399S.
[3]孙娟.口服抗凝剂的妇科手术患者围手术期管理.国际妇产科学杂志,2011,38(4):354-357.
[4]何剑辉，徐嘉文，张斌.心脏换瓣术后妇科围手术期应用抗凝药物的临床分析.广东医学,2012,35（6）：931-933.
[5]复旦大学附属中山医院围手术期处理多学科团队.接受抗凝药物治疗的普外科病人围手术期处理——中山共识（1）.中国实用外科杂志,2013,33(1):1-3.
[6]Teles JS,Fukuda EY，Feder D.Warfarin:pharmacological profile and drug interactions with antidepressants.Einstein (Sao Paulo),2012,10(1):110-115.
[7]Kovacs MJ,Kearon C,Rodger M,et al.Singlearm study of bridging therapy with lowmolecularweight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.Circulation,2004,110(12):1658-1663.
[8]Linkins MJ,Kearon C,Rodger M,et al.Clinical impact of bleeding in patients taking oral anticoagulant therapy of vevous thromboembolism:a metaanalysis.Ann Intern Med,2003,139(11):893-900.
[9]李学强，赵立坤，王玉霞，等.非心脏手术围手术期华法林管理.中国现代医药杂志，2014,16（3）：104-106.
[10]Tompkins C,Cheng A,Dalal D,et al.Dual antiplatelet therapy and heparin bridging significantly increase the risk of bleeding complications after pacemaker orimplantable cardioverterdefibrillator device implantation.J Am Coll Cardiol,2010,55(21):2376-2782.
[11]Thachil J,Gatt A,Martlew V.Management of surgical patients receiving anticoagulation and antiplatelet agents.Br J Surg,2008,95(12):1437-1448.

备注/Memo

备注/Memo:
＊基金项目：北京市教育委员会科技计划一般项目（KM201810025024）**通讯作者，Email：drzhangj@outlook.com
更新日期/Last Update: 2019-03-01